AnalystsMathew Blackman
Mathew Blackman's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Top 15%
#726 out of 5020 analysts
Average Return
+11.4%
Win Rate
55%23 out of 42
Risk vs Reward
Poor
Good

Mathew Blackman's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Adapthealth CorpAHCO
+188.39%$13.27$38.27
2020-01-30 -
2021-01-29
Strong Buy
Dexcom IncDXCM
+180.62%$36.62$102.75
2019-10-22 -
2020-10-23
Strong Buy
Clearpoint Neuro IncCLPT
+129.72%$5.35$12.29
2023-10-23 -
2024-10-23
Strong Buy
Dexcom IncDXCM
+85.58%$48.68$90.33
2019-11-06 -
2020-11-06
Strong Buy
Apollo Endosurgery IncAPEN
+84.33%$5.36$9.88
2022-02-22 -
2023-01-04
Strong Buy

Mathew Blackman's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Inogen IncINGN
6Hold$7.00-15.87%Maintains
4 months ago
Tandem Diabetes Care IncTNDM
5Strong Buy$31.00+154.52%Maintains
5 months ago
Penumbra IncPEN
2Strong Buy$318.00+24.08%Maintains
5 months ago
Clearpoint Neuro IncCLPT
3Strong Buy$25.00+134.52%Maintains
6 months ago
Beta Bionics IncBBNX
1Strong Buy$25.00+8.18%Initiates Coverage On
7 months ago
Insulet CorpPODD
5Hold$293.00-9.07%Maintains
7 months ago
Globus Medical IncGMED
6Strong Buy$94.00+67.20%Maintains
7 months ago
Orthofix Medical IncOFIX
5Strong Buy$24.00+60.64%Upgrades
10 months ago
Cerus CorpCERS
1Strong Buy$3.00+143.90%Maintains
a year ago
Inari Medical IncNARI
1Hold$50.00N/AInitiates Coverage On
a year ago
Dexcom IncDXCM
11Strong Buy$100.00N/AMaintains
a year ago
Alphatec Holdings IncATEC
5Strong Buy$16.00N/AMaintains
a year ago
Adapthealth CorpAHCO
2Hold$11.00N/ADowngrades
2 years ago
Apollo Endosurgery IncAPEN
3Hold$10.00N/ADowngrades
3 years ago
Seaspine Holdings CorpSPNE
1Strong Buy$22.00N/AInitiates Coverage On
5 years ago
Nuvasive IncNUVA
1Strong Buy$64.00N/AInitiates Coverage On
5 years ago
Wright Medical Group NvWMGI
2Hold$30.00N/ADowngrades
5 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.